- The Daily Trade
- Posts
- Market Moves: Congress Targets China Investments, PG&E's Loan Controversy, and Key Stock Updates 🚀
Market Moves: Congress Targets China Investments, PG&E's Loan Controversy, and Key Stock Updates 🚀
Ryan Serkes
December 18, 2024
In partnership with
The Daily Trade delivers sharp, daily insights on the US stock market.
Stay informed, spot trends, and trade with confidence.
DeFi: Shaping the Future of Finance
Explore how DeFi Technologies Inc. (CAD: DEFI & US: DEFTF) bridges traditional finance and the $3T digital asset market. With innovative strategies and global expansion, DeFi is redefining the investment landscape. Gain exposure to Bitcoin, Web3, and beyond with regulated, secure solutions.
Recent Headlines
Technical Analysis Results
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Buy | ULTOSC Buy | STOCH Buy |
On today's installment of Good Buy or Goodbye, ER Shares COO and Chief Investment Strategist Eva Ados joins Market Domination host Julie Hyman to discuss two of the strategist's latest stock trades. First, Ados likes Applovin's (APP) EBITDA margins and is bullish on the mobile app's platform revenue growth: "It's by far the biggest in this category. And the result of it is that app developers are now able to use AI through Applovin to better market their apps, to optimize their their ad campaigns, and to specifically target the right user. That's the only company that offers that. So what's important with this? It's unlike any other AI play, this is an AI play that most people haven't realized that... it's a hidden AI play." Health insurance provider Cigna Group (CI) is Ados' goodbye stock as President-elect Donald Trump recently commented he hopes to "knock out the middleman" when it comes to pharmacy benefit managers (PBMs). "It's hidden through subsidiaries. So it's not that the companies itself are PBMs, but they own other companies inside them that even so, sometimes it's hard for analysts to notice the effect that this... targeting will have to the company overall," Ados explains. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Luke Carberry Mogan.
(Bloomberg) -- Shares of pharmacy benefit managers extended losses Tuesday after Pfizer Inc. Chief Executive Officer Albert Bourla said President-elect Donald Trump is “very committed” to reforming drug-industry middlemen. Most Read from BloombergHow California Sees the World, and ItselfHong Kong's Expat Party Hub Reshaped by Chinese InfluxLondon’s Tube Fares Are Set to Rise by 4.6% Next YearBourla’s remarks, following comments from Trump Monday and continued criticism from members of Congress,
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Buy | ULTOSC Buy | STOCH Buy |
Health insurance providers, including CVS Health (CVS), Cigna (CI), and UnitedHealth (UNH), are under pressure following comments from President-elect Donald Trump. “We're going to knock out the middleman,” Trump said at a press conference on Monday, referring to pharmacy benefit managers (PBM) that negotiate drug prices between the manufacturer and the pharmacy. He added, “We're going to get drug costs down at levels that nobody has ever seen before.” Catalysts Co-hosts Seana Smith and Madison Mills take a closer look at the market moves and the president-elect’s comments. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. This post was written by Naomi Buchanan.
As an investor its worth striving to ensure your overall portfolio beats the market average. But in any portfolio...
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Buy | ULTOSC Buy | STOCH Buy |
Earnings from STLD's steel operations are likely to be significantly lower in the fourth quarter of 2024
Shares of Nucor (NUE) and Steel Dynamics (STLD) were mixed early Tuesday after the steel production
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Buy | ULTOSC Buy | STOCH Buy |
The iShares Core High Dividend ETF (NYSEARCA:HDV) and the Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) are two popular dividend ETFs from blue-chip sponsors. Both are cost-effective options with low expense ratios, feature portfolios of well-known dividend stocks, and have dividend yields ranging from 3.5% to 3.7%. In this article, we’ll go over what separates these ETFs and which is the better choice for dividend investors. What Is the HDV ETF’s Strategy? According to iShares, HDV invests in
This high dividend ETF hits a new 52-week high. Are more gains in store for this ETF?
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Buy | ULTOSC Buy | STOCH Buy |
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Buy | ULTOSC Buy | STOCH Hold |
Waste Management (WM) reachead $209 at the closing of the latest trading day, reflecting a -1.25% change compared to its last close.
HOUSTON, December 16, 2024--WM (NYSE: WM) today announced that its Board of Directors has approved a 10.0% increase in the planned quarterly dividend rate for 2025, from $0.75 to $0.825 per share. This increase brings the annual dividend rate to $3.30 per share, up from $3.00, and marks the company’s twenty-second consecutive year of dividend increases.
We want to hear from YOU!
Your feedback is important to us. We’re always looking for ways to improve and would love to hear your thoughts on how we can make this newsletter even better for you. Whether you have suggestions, ideas, or just want to share what you enjoy most, we’re all ears.
Simply reply to this email with your thoughts. Every comment helps us serve you better.
Thank you for being a valued reader.
How would you rate today's newsletter?If there's anything I can do better, please let me know so I can make improvements! |
Technical Indicator Information
Relative Strength Index (RSI) | Period: 14 days | Overvalued threshold: 70 | Undervalued threshold: 30
Money Flow Index (MFI) | Period: 14 days | Overvalued threshold: 80 | Undervalued threshold: 20
Williams Percent Range (WillR) | Period: 14 days | Overvalued threshold: -20 | Undervalued threshold: -80
Aroon Oscillator (AO) | Period: 14 days | Overvalued threshold: 75 | Undervalued threshold: -75
Moving Average Convergence/Divergence (MACD) | Period: 26/12/9 days | Overvalued threshold: MACD crosses below MACD Signal | Undervalued threshold: MACD crosses above MACD Signal
Stochastic Oscillator (STOCH) | Period: 14/3/3 days | Overvalued threshold: %K crosses below %D above 80 | Undervalued threshold: %K crosses above %D below 20
Commodity Channel Index (CCI) | Period: 20 days | Overvalued threshold: 100 | Undervalued threshold: -100
Bollinger Bands (BBANDS) | Period: 20 days | Overvalued threshold: price >= upper band | Undervalued threshold: price <= lower band
Parabolic Stop and Reverse (SAR) | Period: variable 50 - 100 days | Overvalued threshold: SAR crosses above price | Undervalued threshold: SAR crosses below price
Triple Exponential Average (TRIX) | Period: 15 days | Overvalued threshold: TRIX crosses below 0 | Undervalued threshold: TRIX crosses above 0
Ultimate Oscillator (ULTOSC) | Period: 28/14/7 days | Overvalued threshold: 70 | Undervalued threshold: 30
Directional Movement Index (DMI) | Period: 14 days | Overvalued threshold: PlusDI crosses below MinusDI | Undervalued threshold: PlusDI crosses above MinusDI
Average Directional Index (ADX) | Period: variable 14 days | Requirement: >= 25
Analysis is only performed on securities with market caps in excess of $100 million and with daily trade volume in excess of $50 million.
Disclaimers
The information in our newsletter is not intended to constitute investment advice and is not designed to meet your personal financial situation. It is provided for information purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor or a group of investors. It should not be assumed that any investments in securities, companies, sectors or markets identified and described will be profitable. We strongly advise you to discuss your investment options with your financial advisor prior to making any investments, including whether any investment is suitable for your specific needs.
Although we obtain information contained in our newsletter from sources we believe to be reliable, we cannot guarantee its accuracy. The analysis provided in this newsletter is based on the prior trading day’s closing prices and may not reflect after-hours trading, earnings announcements, or other significant market events that occur outside regular trading hours. As such, any data or commentary may not fully capture the latest market movements or emerging factors. For the most current and comprehensive view, please consider additional sources or consult with a qualified financial professional.
The information provided in our newsletter is private, privileged, and confidential information, licensed for your sole individual use as a subscriber. We reserve all rights to the content of this newsletter. Forwarding, copying, disseminating, or distributing this newsletter in whole or in part, including substantial quotation of any portion the publication or any release of specific investment recommendations, is strictly prohibited.